Associate Health Minister with responsibility for Pharmac David Seymour has welcomed the increased availability of medicines for Kiwis resulting from the Government’s increased investment in Pharmac.

Pembrolizumab - branded as Keytruda - will be funded from October 1, 2024, for eligible people with advanced triple-negative ...

Second treatment, Bevacizumab is used on liver and ovarian cancer - and would be funded by next April. Pharmac Chief Medical Officer, David Hughes, says offering them will have a wide effect, and ...

Every day eight New Zealanders are diagnosed with a form of blood cancer, including leukaemia, lymphoma, or * Leukaemia and ...

"The vision and determination of our suffragists laid the groundwork for the global equal rights movement," Grigg noted.

This is in addition to a $6.3 billion funding boost to Pharmac over the next four years to widen access to important and life-saving medicines. “We’re also working to improve our education system, ...

This is in addition to a $6.3 billion funding boost to Pharmac over the next four years to widen access to important and life-saving medicines. "We're also working to improve our education system, ...

New Medsafe advice says nitrous products -- or nangs -- sold for recreational use, now fall under the Psychoactive Substances Act, meaning potential fines or jail time. Health Minister Dr Shane Reti, ...

The Associate Health Minister’s letter of expectations for Pharmac includes things that could fundamentally alter its core ...